Avadel Pharmaceuticals Enters into Exclusive Negotiations with Serenity Pharmaceuticals for Noctiva™


DUBLIN, Ireland, Aug. 18, 2017 (STL.NEWS) — Avadel Pharmaceuticals plc (NASDAQ:AVDL) (“Avadel”), today announced that it has entered into an agreement for the right to exclusively negotiate with Serenity Pharmaceuticals, LLC (“Serenity”), fo…
http://bit.ly/2v8ok6o

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s